Evidence map›Paper›PMID 25126726›Full record

ArticleAutophagy2014

FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation.

Elaine A Dunlop, Sara Seifan, Tijs Claessens, Christian Behrends, Miriam Af Kamps, Ewelina Rozycka, Alain J Kemp, Ravi K Nookala, John Blenis, Barry J Coull and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Autophagy induction promoted by mNature communications · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 9 countries.

Elaine A DunlopInstitute of Cancer and Genetics, Cardiff University; Heath Park, Cardiff, Wales UK.
Sara SeifanInstitute of Cancer and Genetics, Cardiff University; Heath Park, Cardiff, Wales UK.
Tijs ClaessensInstitute of Cancer and Genetics, Cardiff University; Heath Park, Cardiff, Wales UK; Department of Dermatology; GROW School for Oncology and Developmental Biology; Maastricht University Medical Center; Maastricht, Netherlands.
Christian BehrendsFrankfurt Institute for Molecular Life Sciences (FMLS) and Institute of Biochemistry II; Goethe University School of Medicine; Frankfurt, Germany.
Miriam Af KampsDepartment of Dermatology; GROW School for Oncology and Developmental Biology; Maastricht University Medical Center; Maastricht, Netherlands.
Ewelina RozyckaCentre for Cancer Research and Cell Biology; School of Medicine, Dentistry and Biomedical Science; Queen's University Belfast; Belfast, UK.
Alain J KempInstitute of Genetics and Molecular Medicine; Edinburgh Cancer Research UK Centre; University of Edinburgh; Edinburgh, UK.
Ravi K NookalaDepartment of Biochemistry; University of Cambridge; Cambridge, UK.
John BlenisDepartment of Cell Biology; Harvard Medical School; Boston, MA USA.
Barry J CoullDepartment of Dermatology; GROW School for Oncology and Developmental Biology; Maastricht University Medical Center; Maastricht, Netherlands.
James T MurrayCentre for Cancer Research and Cell Biology; School of Medicine, Dentistry and Biomedical Science; Queen's University Belfast; Belfast, UK; Trinity Biomedical Sciences Institute; School of Biochemistry and Immunology; Trinity College; Dublin, Ireland.
Maurice Am van SteenselDepartment of Dermatology; GROW School for Oncology and Developmental Biology; Maastricht University Medical Center; Maastricht, Netherlands; Immunos; Institute of Medical Biology; Singapore.
Simon WilkinsonInstitute of Genetics and Molecular Medicine; Edinburgh Cancer Research UK Centre; University of Edinburgh; Edinburgh, UK.
Andrew R TeeInstitute of Cancer and Genetics, Cardiff University; Heath Park, Cardiff, Wales UK.
Children's Oncology Group · CHCardiff University · GBEdinburgh Cancer Research · GBQueen's University Belfast · GBGoethe University Frankfurt · DEHarvard University · USUniversity of Cambridge · GB

Funding

SIGNAL TRANSDUCTION TO PP70 S6KR01GM051405 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLENIS, JOHN · 1995 to 2023
$14.0M
Cancer Research UK 12825Cancer Research UK C20685/A12825NIGMS NIH HHS R01 GM051405
6 · The paper itself

Abstract

Birt-Hogg-Dubé (BHD) syndrome is a rare autosomal dominant condition caused by mutations in the FLCN gene and characterized by benign hair follicle tumors, pneumothorax, and renal cancer. Folliculin (FLCN), the protein product of the FLCN gene, is a poorly characterized tumor suppressor protein, currently linked to multiple cellular pathways. Autophagy maintains cellular homeostasis by removing damaged organelles and macromolecules. Although the autophagy kinase ULK1 drives autophagy, the underlying mechanisms are still being unraveled and few ULK1 substrates have been identified to date. Here, we identify that loss of FLCN moderately impairs basal autophagic flux, while re-expression of FLCN rescues autophagy. We reveal that the FLCN complex is regulated by ULK1 and elucidate 3 novel phosphorylation sites (Ser406, Ser537, and Ser542) within FLCN, which are induced by ULK1 overexpression. In addition, our findings demonstrate that FLCN interacts with a second integral component of the autophagy machinery, GABA(A) receptor-associated protein (GABARAP). The FLCN-GABARAP association is modulated by the presence of either folliculin-interacting protein (FNIP)-1 or FNIP2 and further regulated by ULK1. As observed by elevation of GABARAP, sequestome 1 (SQSTM1) and microtubule-associated protein 1 light chain 3 (MAP1LC3B) in chromophobe and clear cell tumors from a BHD patient, we found that autophagy is impaired in BHD-associated renal tumors. Consequently, this work reveals a novel facet of autophagy regulation by ULK1 and substantially contributes to our understanding of FLCN function by linking it directly to autophagy through GABARAP and ULK1.

Indexed as

AutophagyAdaptor Proteins, Signal TransducingAmino Acid SequenceAnimalsApoptosis Regulatory ProteinsAutophagy-Related Protein-1 HomologBirt-Hogg-Dube SyndromeCarrier ProteinsHumansIntracellular Signaling Peptides and ProteinsMiceMicrotubule-Associated ProteinsMolecular Sequence DataPhosphorylationProtein BindingProtein Serine-Threonine KinasesAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsAutophagy-Related Protein-1 HomologCarrier ProteinsFLCN protein, humanFNIP1 protein, humanFNIP2 protein, humanGABARAP protein, humanIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsProtein Serine-Threonine KinasesProto-Oncogene ProteinsSequestosome-1 ProteinSQSTM1 protein, humanTumor Suppressor ProteinsULK1 protein, humanautophagyBHDFLCNGABARAPMAP1LC3BSQSTM1ULK1

Identifiers

PMID25126726
PMCPMC4198360
OpenAlexW2043287555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.